These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3414675)

  • 1. Toxic effects of aluminum in end-stage renal disease: discussion of a case.
    Coburn JW; Norris KC; Sherrard DJ; Bia M; Llach F; Alfrey AC; Slatopolsky E
    Am J Kidney Dis; 1988 Sep; 12(3):171-84. PubMed ID: 3414675
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoptysis and altered sensorium in a hemodialysis patient.
    Olivero JJ
    Hosp Pract (Off Ed); 1993 Mar; 28(3A):77-8. PubMed ID: 8450006
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid aluminum levels following deferoxamine.
    Ellenberg R; King AL; Sica DA; Posner M; Savory J
    Am J Kidney Dis; 1990 Aug; 16(2):157-9. PubMed ID: 2382654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of tumoral calcinosis after the appropriate control of a deranged mineral and bone metabolism, in conjugation with cinacalcet hydrochloride treatment, in a chronic hemodialysis patient.
    Yamada S; Tsuruya K; Kitazono T
    Ther Apher Dial; 2013 Jun; 17(3):348-9. PubMed ID: 23735152
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aluminum and iron deposition in dialysis patients].
    Kurihara S; Marumo F
    Nihon Rinsho; 1992 Jan; 50 Suppl():905-10. PubMed ID: 1578787
    [No Abstract]   [Full Text] [Related]  

  • 8. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    Lillevang ST; Pedersen FB
    Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071
    [No Abstract]   [Full Text] [Related]  

  • 9. Brown tumour involving the orbit: case report and review of the literature.
    Borbolla-Pertierra AM; Guinto-Arcos E; Rodríguez-Reyes A; Graue-Moreno G; Olvera-Morales O
    Can J Ophthalmol; 2016 Aug; 51(4):e125-e127. PubMed ID: 27521680
    [No Abstract]   [Full Text] [Related]  

  • 10. Autonomous hyperparathyroidism in patients on maintenance home dialysis.
    Lehman CA; Schreiber MH
    AJR Am J Roentgenol; 1976 Sep; 127(3):377-80. PubMed ID: 183519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferoxamine therapy of bone aluminum accumulation in renal dialysis patients.
    Nutr Rev; 1985 Apr; 43(4):103-5. PubMed ID: 3923410
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful removal of aluminium from patient with dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP; Hodge KC
    Lancet; 1980 Sep; 2(8196):692-3. PubMed ID: 6106803
    [No Abstract]   [Full Text] [Related]  

  • 13. Recognition and management of aluminum intoxication in children.
    Tsuru N; Williams JL; Chan JC
    Int J Pediatr Nephrol; 1987; 8(3):177-86. PubMed ID: 3323095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature].
    Seidowsky A; Dupuis E; Drueke T; Dard S; Massy ZA; Canaud B
    Nephrol Ther; 2018 Feb; 14(1):35-41. PubMed ID: 29174672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemistry of desferrioxamine chelation for aluminum overload in renal dialysis patients.
    Day JP; Ackrill P
    Ther Drug Monit; 1993 Dec; 15(6):598-601. PubMed ID: 8122301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum kinetics of the REDY system: a study of the impact of deferoxamine therapy.
    Culpepper CP; Cummings R; Westervelt FB; Savory J; Wills MR
    Trans Am Soc Artif Intern Organs; 1983; 29():76-80. PubMed ID: 6673321
    [No Abstract]   [Full Text] [Related]  

  • 17. Brown tumor of the orbit. Case report and review of the literature.
    Parrish CM; O'Day DM
    Arch Ophthalmol; 1986 Aug; 104(8):1199-202. PubMed ID: 3741252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 19. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
    Válek A; Sulková S; Laurinová Z
    Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
    [No Abstract]   [Full Text] [Related]  

  • 20. An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis.
    Chen CL; Chen NC; Hsu CY; Chou KJ; Lee PT; Fang HC; Renn JH
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2426-32. PubMed ID: 24670088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.